PWP
CVS icon

Principle Wealth Partners’s CVS Health CVS Stock Holding History

Principle Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
20,714
+1
+0% +$89 0.11% 135
2026
Q1 		$1.49M Buy
20,713
+1
+0% +$77 0.09% 145
2025
Q4 		$1.64M Sell
20,712
-1,057
-5% -$83.3K 0.09% 138
2025
Q3 		$1.64M Sell
21,769
-67
-0.3% -$4.59K 0.1% 130
2025
Q2 		$1.51M Buy
21,836
+43
+0.2% +$2.82K 0.09% 128
2025
Q1 		$1.48M Sell
21,793
-303
-1% -$18.1K 0.11% 133
2024
Q4 		$992K Sell
22,096
-1,674
-7% -$93.9K 0.07% 154
2024
Q3 		$1.49M Buy
23,770
+2,055
+9% +$120K 0.11% 133
2024
Q2 		$1.28M Sell
21,715
-9,325
-30% -$583K 0.1% 139
2024
Q1 		$2.48M Buy
31,040
+843
+3% +$64.4K 0.19% 111
2023
Q4 		$2.38M Sell
30,197
-4,523
-13% -$322K 0.21% 109
2023
Q3 		$2.42M Sell
34,720
-1,679
-5% -$119K 0.24% 95
2023
Q2 		$2.52M Buy
36,399
+679
+2% +$48.3K 0.25% 89
2023
Q1 		$2.65M Sell
35,720
-198
-0.6% -$16.6K 0.28% 84
2022
Q4 		$3.35M Buy
35,918
+8,368
+30% +$807K 0.38% 66
2022
Q3 		$2.63M Sell
27,550
-7,842
-22% -$776K 0.25% 75
2022
Q2 		$3.28M Buy
35,392
+9,259
+35% +$904K 0.39% 61
2022
Q1 		$2.65M Sell
26,133
-403
-2% -$42.3K 0.28% 81
2021
Q4 		$2.74M Buy
26,536
+419
+2% +$38.7K 0.29% 74
2021
Q3 		$2.22M Buy
26,117
+443
+2% +$37.1K 0.26% 82
2021
Q2 		$2.14M Sell
25,674
-1,357
-5% -$111K 0.24% 85
2021
Q1 		$2.03M Sell
27,031
-120
-0.4% -$8.74K 0.24% 89
2020
Q4 		$1.85M Buy
27,151
+5,531
+26% +$360K 0.24% 84
2020
Q3 		$1.26M Sell
21,620
-327
-1% -$20.3K 0.35% 46
2020
Q2 		$1.43M Hold
21,947
– – 0.42% 40
2020
Q1 		$1.3M Sell
21,947
-142
-0.6% -$9.48K 0.49% 37
2019
Q4 		$1.64M Hold
22,089
– – 0.52% 42
2019
Q3 		$1.39M Buy
+22,089
New +$1.31M 0.48% 46

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Principle Wealth Partners's CVS Position: Q2 2026 in Review

Principle Wealth Partners increased its CVS Health (CVS) stake by 0% in Q2 2026, buying an estimated $89 and bringing the position to 20,714 shares worth $2.14M. The position accounts for 0.11% of the portfolio, ranked #135.

Principle Wealth Partners first reported a position in CVS in Q3 2019 and has held it in 28 quarters since. The position peaked at $3.35M in Q4 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Principle Wealth Partners held 20,714 shares of CVS Health worth $2.14M as of Q2 2026.
  • Principle Wealth Partners bought 1 CVS Health share in Q2 2026, an estimated $89.
  • CVS Health made up 0.11% of Principle Wealth Partners's portfolio in Q2 2026, its #135 holding.
  • Principle Wealth Partners first reported a position in CVS Health in Q3 2019 and has held it in 28 quarters since.
  • Principle Wealth Partners's CVS Health position peaked at $3.35M in Q4 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Principle Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.